via UNC Chapel Hill
Lab tests at UNC-Chapel Hill Gillings School of Global Public Health demonstrate swine coronavirus replicates in human airway and intestinal cells.
New research from the University of North Carolina at Chapel Hill suggests that a strain of coronavirus that has recently alarmed the swine industry has the potential to spread to humans as well.
The coronavirus strain, known as swine acute diarrhea syndrome coronavirus (SADS-CoV), emerged from bats and has infected swine herds throughout China since it was first discovered in 2016. Outbreaks of such an illness have the potential to wreak economic havoc in many countries across the globe that rely on the pork industry.
The virus’ potential threat to people was demonstrated in lab tests at UNC-Chapel Hill Gillings School of Global Public Health showing SADS-CoV efficiently replicated in human airway and intestinal cells. The findings were published Oct. 12 in PNAS.
Though it is in the same family of viruses as the betacoronavirus SARS-CoV-2, which causes the respiratory illness COVID-19 in humans, SADS-CoV is an alphacoronavirus that causes gastrointestinal illness in swine. The virus causes severe diarrhea and vomiting and has been especially deadly to young piglets.
SADS-COV is also distinct from two circulating common cold alphacoronaviruses in humans, HCoV-229E and HCoV-NL63.
“While many investigators focus on the emergent potential of the betacoronaviruses like SARS and MERS, actually the alphacoronaviruses may prove equally prominent — if not greater — concerns to human health, given their potential to rapidly jump between species,” said Ralph Baric, professor of epidemiology at Gillings and chair of the scientific advisory board of the Rapidly Emerging Antiviral Drug Discovery Initiative (READDI).
While SADS-CoV has not been known to affect humans to-date, the COVID-19 pandemic serves as a potent reminder that many coronavirus strains found in animals have the potential to infect humans as well – an effect known as spillover.
The Baric lab worked with Caitlin Edwards, a research specialist and master of public health student at UNC-Chapel Hill, on the study which suggests humans may be susceptible to spillover of SADS-CoV.
Edwards, the study’s first author, tested several types of cells by infecting them with a synthetic form of SADS-CoV to understand just how high the risk of cross-species contamination could be.
Evidence from the study indicates that a wide range of mammalian cells, including primary human lung and intestinal cells, are susceptible to infection. According to Edwards, SADS-CoV shows a higher rate of growth in intestinal cells found in the human gut, unlike SARS-CoV-2, which primarily infects lung cells.
Cross-protective herd immunity often prevents humans from contracting many coronaviruses found in animals. However, results from the testing done by Edwards and her team suggest that humans have not yet developed such immunity to SADS-CoV.
“SADS-CoV is derived from bat coronaviruses called HKU2, which is a heterogenous group of viruses with a worldwide distribution,” Edwards said. “It is impossible to predict if this virus, or a closely related HKU2 bat strain, could emerge and infect human populations. However, the broad host range of SADS-CoV, coupled with an ability to replicate in primary human lung and enteric cells, demonstrates potential risk for future emergence events in human and animal populations.”
In response to these findings, Edwards and colleagues tested the broad-spectrum antiviral remdesivir as a potential method of treatment for the infection.
Working with Gilead Sciences, remdesivir was developed by the Baric Lab to combat all known coronaviruses, including SADS-CoV. It is currently being used to treat COVID-19 infections in humans, including the United States president. Preliminary results from this study show that it has robust activity against SADS-CoV, though Edwards cautions that more testing is necessary on additional cell types and in animals to confirm these findings.
“Promising data with remdesivir provides a potential treatment option in the case of a human spillover event,” she said. “We recommend that both swine workers and the swine population be continually monitored for indications of SADS-CoV infections to prevent outbreaks and massive economic losses.”
SADS-CoV could also pose a threat to the U.S. economy, which was third in global pork production in 2019. In 2012, the U.S. pork industry was devastated by different swine coronavirus that emerged from China.
“Not surprisingly, we are currently looking for partners to investigate the potential of SADS-CoV vaccine candidates to protect swine,” Baric said. “While surveillance and early separation of infected piglets from sows provide an opportunity to mitigate larger outbreaks and the potential for spillover into humans, vaccines may be key for limiting global spread and human emergence events in the future.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Coronavirus shutdowns have quashed nearly all other common viruses. But scientists say a rebound is coming.on January 12, 2021 at 5:05 am
Veteran virus trackers say they are chronicling something never before seen — the suppression of virtually every common respiratory and gastrointestinal virus besides the novel coronavirus. They ...
- Illinois Department of Public Health chooses Juvare EMTrack for COVID-19 Vaccination Scheduling, Tracking, and Reportingon January 12, 2021 at 5:00 am
Juvare, the leader in critical incident preparedness and response technology, announced today that it has partnered with the ...
- How a Well-Meaning Health Policy Created California’s Coronavirus Nightmareon January 12, 2021 at 4:00 am
Everyone’s worst pandemic nightmare is happening in Los Angeles. Intensive-care units are overflowing with patients gasping for breath, and there might not be enough ventilators to go around. If a ...
- Cooper Umbrell raises a show pig in his backyardon January 11, 2021 at 3:00 am
He planned to show "Chunk," his Cross Breed hog at this year's Pennsylvania Farm Show until the competition was canceled because of the coronavirus pandemic.
- mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industryon January 11, 2021 at 2:15 am
BioNTech vaccine and a similar one from Moderna being slowly rolled out across the U.S. and Europe, RNA has been deployed to make a whole new type of vaccine that will, when it reaches enough people, ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Human emergence events
- 20 major world events in 2020on December 30, 2020 at 3:34 am
(COVID-19) worldwide. But besides this, it can be said that 2020 is also a busy year in terms of the diversity of political, economic, and social events. In the continuation of this report, 20 ...
- Rave Warri; An indigenous event franchise attracting investors to Warri, Delta stateon December 29, 2020 at 8:25 am
The social and event industry around the world has witnessed ... leaving a wide gap in the structure of human interactions and experiences. Nonetheless, as a nation richly blessed with a ...
- Genome sequencing for all international patients if tested Covid-19 positive: Why it is needed?on December 29, 2020 at 7:12 am
Also Read - Online tool identifies Covid patients at highest risk of deterioration: Study India had imposed a temporary suspension on flights coming from UK following reports of the emergence of a ...
- 2021 Prediction: The Rise Of AuthenTechon December 28, 2020 at 3:01 pm
If 2020 has taught us anything, it’s that there’s never a shortage of unpredictable events ahead of us ... I feel confident in making is the emergence of a new technical business category.
- Emergence and Control of Zoonotic Viral Encephalitison December 24, 2020 at 4:00 pm
Numerous presentations demonstrated that we are beginning to understand the molecular mechanisms leading to pathogenetic events ... emergence and for preventing zoonotic diseases from reaching ...